{
    "2018-10-16": [
        [
            {
                "time": "2018-09-14",
                "original_text": "Alnylam to Pursue Full Approval & Rolling NDA for Givosiran",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Full Approval",
                        "Rolling NDA",
                        "Givosiran"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-30",
                "original_text": "Tesla Jumps After Judge Makes SEC Settlement Official: LIVE MARKETS BLOG",
                "features": {
                    "keywords": [
                        "Tesla",
                        "Jumps",
                        "SEC Settlement",
                        "Judge"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "automotive",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Benchmark Out Bullish On 'Well-Positioned' Tilray Ahead of Canada's Cannabis Legalization",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Bullish",
                        "Cannabis Legalization",
                        "Canada"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-16",
                "original_text": "Tilray Jumps After $200 Price Target and 'Buy' Rating: LIVE MARKETS BLOG",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Jumps",
                        "$200 Price Target",
                        "Buy Rating"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Tilray Jumps After $200 Price Target and Bullish Rating at Benchmark",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Jumps",
                        "$200 Price Target",
                        "Bullish Rating",
                        "Benchmark"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "Roche Announces Positive Data on Breast Cancer Drug Kadcyla",
                "features": {
                    "keywords": [
                        "Roche",
                        "Positive Data",
                        "Breast Cancer",
                        "Kadcyla"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Novartis",
                        "AbbVie",
                        "blockbuster drug",
                        "EU"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Tilray's stock surges after Benchmark starts coverage with bullish rating, $200 target",
                "features": {
                    "keywords": [
                        "Tilray",
                        "stock surges",
                        "Benchmark",
                        "bullish rating",
                        "$200 target"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Novartis To Present Five-year Data From Phase III Studies For Cosentyx",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Five-year Data",
                        "Phase III Studies",
                        "Cosentyx"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}